One of the main reasons for failure of chemotherapy is believed to be the emergence of cellular drug resistance. It is therefore very important to identify mechanisms of drug resistance in order to improve the clinical efficacy of chemotherapy. Vindesine is one of the effective drugs against human small-cell lung cancer (Bunn et al., 1989) . Resistance to vinca alkaloids and taxol involves the multidrug resistant phenotype caused by the mdrl gene product, P-glycoprotein. However, mechanisms other than P-glycoprotein mediated drug efflux may also be important in clinical resistance of human lung cancer (Lai et al., 1989) . We have tried to establish a vindesine-resistant human small-cell lung cancer cell line with a different mechanism to that of the typical mdrl mediated multidrug resistance. We were successful in establishing a vindesine-resistant cell line without elevated expression of the mdrl gene or increased drug efflux. We believe that this vindesine-resistant cell line is unique and may be useful in elucidating the vindesine resistance mechanism in human small-cell lung cancer.
Materials and methods

Chemicals
Vindesine and vincristine were purchased from Shionogi Pharmaceutical Co. (Osaka, Japan). Taxol, cisplatin and etoposide were obtained from Bristol-Myers Squibb (Tokyo, Japan). Doxorubicin was purchased from Kyowa Hakko Kogyo (Tokyo). RPMI 1640 medium and phosphate-buffered saline (PBS) were purchased from Nissui (Tokyo). Anti-atubulin antibody was purchased from Seikagaku Corporation (Tokyo) (National Cancer Center Research Institute, Tokyo, Japan). The cells were propagated in RPMI 1640 medium supplemented with 10% heat-inactivated foetal bovine serum, penicillin (100 IU x ml-') and streptomycin (100 gig x ml-') (RPMI-FBS) at 37°C in a balanced air humidified incubator with an atmosphere of 5% CO2. The resistant cell line was developed by the continuous exposure to vindesine starting with 0.1 nM and increased in a stepwise manner to 10 nM. We isolated a H69 subline resistant to vindesine-induced growth inhibition (H69/VDS) by twice using a limiting dilution method. Briefly, we placed 150 gil of medium containing 10 nM of vindesine into each well of a 96-well tissue culture plate. We added 1501gI of cell suspension (1 x 103 cells x ml-') containing 10 nM vindesine to the first set of wells.
We then transfered half of the cell suspension from these wells to the next group of wells and diluted by 2-fold with medium. We repeated the dilution procedure until a proportion of wells contained only a single cell. We then incubated the plates for a period of one month. In some wells a colony was produced from a single cell. The established vindesineresistant cell line was obtained from such a colony and grew continuously in medium containing 10 nM vindesine. The cells were used in experiments after being cultivated in drugfree medium for 7 days.
Doxorubicin resistant K562/ADM cells (Tsuruo et al., 1986) and etoposide resistant H69/VP cells (Minato et al., 1990) were used as positive controls for typical mdrl expressing cells.
Growth-inhibitory assay
To determine the growth-inhibitory effects of the drugs, we used the tetrazolium dye assay of Mosmann (1983 (Versantvoort et al., 1992) . Cells were washed twice with ice-cold PBS and cell pellets after centrifugation were dissolved with 2001lI of dimethyl sulfoxide, and then cellular proteins were precipitated by the addition of 1.8 ml of absolute methanol. The fluorescence intensity of the extracts was determined using a fluorescence spectrophotometer (FP-777; Japan Spectroscopic Co., Ltd., Tokyo, Japan) at excitation and emission wave-lengths of 470 and 550nm, respectively (Horichi et al., 1990) .
RNA extraction and Northern blot analysis RNA was extracted from the parent and vindesine-resistant cell lines by the acid guanidinium thiocyanate-phenolchloroform extraction method (Chomczynski & Sacchi, 1987) . Twenty ltg of total RNA was electrophoresed on a 1% agarose-6% formaldehyde gel at 25 V for 12 h. The RNA was transferred to a positively charged nylon membrane (Hybond-N+, Amersham Japan), which was then hybridised overnight with a 32P-labelled DNA probe at 42°C. The probe was labelled with [x-32PJ-dCTP by means of a multiprime labelling system kit (Amersham Japan). After hybridisation, the membrane was washed three times with 2 x SSC (1 x SSC consists of 0.15 M NaCl and 0.015 M sodium citrate) and 0.1% SDS for O min. After 3 x washes with 0.1 x SSC and 0.1% SDS for 15 min at 65°C, followed by several washes with 0.1 x SSC, the membrane was autoradiographed on X-ray film (Amersham Hyperfilm-MP) at -70°C for 3 days. The probe used, pmdrl (coding for human mdrl) (Roninson et al., 1986) collected and adjusted to 5 x 105 cells x ml-'. One ml of each cell suspension was centrifuged at 200 g for 5 min, and resuspended in 0.3 ml of depolymerisation buffer (0.1 M MES, 1 mM MgSO4, 10 mM CaC12, 5 mM GTP, pH 6.9). Cells were lysed by sonication on ice with a Branson Sonifier 450 (Branson ultrasonics, Danbury, CT) at 15 W output for two intervals of 15 s each. Lysate fractions were incubated in depolymerisation buffer for 1 h on ice to depolymerise the microtubules. Following depolymerisation, samples were centrifuged at 50,000g for 15min at 4°C using a TL-100 centrifuge (Beckman) with a fixed-angle TL-45 rotor. The supernatant was transferred to a new centrifuged tube. After addition of 30 jtl protein G sephrose 4 Fast Flow (Pharmacia-LKB) and overnight mixing at 4°C, the tube was centrifuged at 250 g for 5 min. The supernatant was transferred to a new centrifuge tube, anti-x-tubulin antibody was added and the tube mixed for 1 h at 4°C. To each sample was then added 30 yl protein G sephrose followed by mixing for 1 h at 4°C and washing with 3 times depolymerisation buffer. To the pellet was added 50 tl SDS sample buffer (0.25 M Tris-HCI, 2% sodium dodecyl sulfate (SDS), 30% glycerol, 10% 2-mercaptoethanol, 0.01% bromophenol blue pH 6.8), and the mixture was then denatured at 90°C for 1 min and subjected to electrophoresis in a 10% SDSpolyacrylamide gel (PAG PLATE 10, Daiichi Pure Chemicals). The separated protein was stained using a silver stain (Sil-best Stain, Nacalai Tesque).
Preparation of whole cell lysates for determination of the polymerised tubulin content Polymerised tubulin was isolated by a modification of the Thrower and Minotti method. Briefly, exponentially growing cells were washed twice with warm PBS, collected and adjusted to 5 x 105 cells x ml-. One ml of each cell suspension was centrifuged at 200 g for 5 min. The pellet was resuspended in 1 ml of stabilisation buffer (20 mM Tris-HCl, pH 6.8, 0.14 M NaCl, 0.5% Nonidet P-40, 1 mM MgCl2, 2 mM EGTA, 4 ltg ml1' taxol) and incubated at 37°C for 30 min. Each sample was centrifuged at 50,000 g for 15 min at 37°C. The supernatant was aspirated and the pellet was resuspended with 0.3 ml of depolymerisation buffer. Following this step the lysate was treated in a similar manner to the total tubulin isolates, with 1 h incubation on ice, centrifugation, immunoprecipitation, and electrophoresis.
Western blot analysis for total and polymerised tubulin Total and polymerised tubulin contents were analysed on a 10% SDS-polyacrylamide gel. Following electrophoresis, the protein on the gel was electrophoretically transferred to nitrocellulose membranes (Towbin et al., 1979) . The membrane was incubated with blocking buffer (4% skimmed milk in PBS for 1 h and was then allowed to react with anti-atubulin antibody for 12 h at 4°C. After incubation, the membrane was washed four times with PBS containing 0.1% tween-20 and then incubated with biotinylated anti-mouse IgG antibody at room temperature for 1 h. The bands were detected by the ECL Western blotting detection method (Amersham), and analysed with a Ultroscan XL enhanced laser densitometer (Pharmacia LKB). Table I Table II . The relative resistance of H69/ VDS was highest against vindesine (x 11.6) and crossresistance to vincristine (x 6.9), colchicine (x 3.4) and taxol (x 10.1) was evident (P<0.01, unpaired Student t-test). H69/ VDS did not show high cross-resistance to other drugs such as doxorubicin (x 1.53), etoposide (x 0.87) or cisplatin (x 0.61). There were no significant differences in the ICso's value for these drugs between H69 and H69/VDS by unpaired Student t-test. The resistance pattern of H69/VDS cells was therefore different from that of the typical multidrug resistance phenotype. It was interesting to note that H69/VDS cells had cross-resistance not only to vincristine, colchicine but also to taxol, which has a different mechanism of action on tubulin compared with vinca alkaloids (Schiff et al., 1979; Schiff & Horwitz, 1980 (Figure 2 ). Figure 3 ).
Results
General characteristics Data in
Reversal of vindesine resistance by verapamil
We examined the effect of Ca2"-channel blocker, verapamil on vindesine cytotoxicity in H69 and H69/VDS cells. We also evaluated the toxicity of verapamil alone on H69 and H69/ VDS cells using a dose range of 0.1 JM to 1,000 tLM. (Table IV) . These results suggest that the reversal of vindesine-resistance in H69/VDS by verapamil could not be explained by an increase in the intracellular accumulation of vincristine. Considering that H69/VDS cells neither expressed mdrl mRNA nor had reduced intracellular retention of vincristine reversal of vindesine-resistance by verapamil must be based on a mechanism other than decreased drug efflux induced by verapamil.
Tubulin content
We examined other mechanisms which might possibly be responsible for resistance to tubulin-acting agents in H69/ VDS. As H69/VDS showed cross-resistance to vindesine, vincristine, colchicine, and taxol, drugs which are known to intereact with microtubules, we considered that changes in tubulin might be related to the resistance of H69/VDS cells. To determine whether verapamil affects the total and polymerised tubulins in H69/VDS and H69 cells, we measured by immunoprecipitation the total and polymerised tubulin contents after incubating cells in the presence or absence of 20 JM verapamil (Figure 6 ). The polymerised tubulin ratio is defined as the ratio of polymerised tubulin content to total tubulin content. The polymerised tubulin ratio in H69/VDS in the absence of verapamil was higher than that of H69. In H69, 201 M of verapamil slightly increased the amount of total and polymerised tubulins, but the polymerised tubulin ratio remained unchanged. On the other hand, in H69/VDS, 20 JM of verapamil increased the amount of the total tubulin, but decreased the amount of polymerised tubulin resulting in a decrease in the polymerised tubulin ratio. This effect of verapamil on the total and polymerised tubulins in H69/VDS is consistent with the reversal of resistance by verapamil in H69/VDS. The decreased polymerised tubulin ratio caused by the addition of verapamil might explain the reversal of vindesine and vincristine resistance in H69/VDS. Dose and time dependent effects of verapamil on the amount of the total tubulin We observed two bands of 68 and 54 kDa by immunoprecipitation assay. The 68 kDa band was not detected by Western blot analysis and so this band was considered to be the tubulin-related protein. The 54 kDa band was identified as a-tubulin by reblotting. Total x-tubulin content of H69/ VDS cells was significantly lower than that of the H69 parental cells (Figure 6 ). The time and dose dependent effects of verapamil on tubulin content were evaluated. The total tubulin content was increased in H69/VDS, as the concentration verapamil was increased from 5 to 10 20 JAM (Figure 7a (Figure 8 ).
The total tubulin content after exposure to 0.1 to 20 JLM of verapamil was higher than that without verapamil in H69/ VDS. Whereas the polymerised tubulin content was decreased. The polymerised tubulin ratio was therefore decreased by the co-incubation with verapamil.
Discussion
Resistance to vinca alkaloids and taxol has been reported to involve the typical P-glycoprotein mediated multidrug resistance and increased drug efflux (Roy & Horwitz, 1985; Beck, 1987) . In the vindesine resistant small-cell lung cancer cell line, H69/VDS which we established, cross-resistance to tubulin interacting agents such as vindesine, vincristine, colchicine and taxol was apparent (Table II) involved for the resistance of H69/VDS. The site of action of vinca alkaloids is generally considered to be on the microtubules. We therefore considered that some changes in the tubulin might be related to the resistance of H69/VDS. By immunoprecipitation with anti-o-tubulin antibody for the comparison of the tubulin content of H69 and H69/VDS cells two bands of 68 and 54 kDa were observed. The 54 kDa band was identified as a-tubulin. On the other hand the 68 kDa band was not detected by Western blotting. At first we were interested in 68 kDa immunoprecipitated protein.
There is a possibility that the 68 kDa immunoprecipitated protein is the 68 kDa microtubule associated protein (Lim et al., 1984) or a heat-shock protein 70 (Lee et al., 1992) . However, the change in the amount of the 68 kDa immunoprecipitated protein was not reproducible in several experiments. Because of these findings, we did not consider that the 68 kDa protein was responsible for the resistance to vindesine in H69/VDS cells. Verapamil increased the total cellular tubulin content (Figure 8) . We investigated the synthesis of the total atubulin content using a [35S]-methionine label to determine whether the effect of verapamil in increasing in the total tubulin content was due to an increase in synthesis. We did not, however, observe any increase in the synthesis of the total tubulin by the verapamil in H69/VDS (data not shown). We are now investigating the possibility that verapamil might influence the tubulin turnover.
As shown in the present study, the total and polymerised tubulin contents of H69/VDS were lower than those of parental H69 cells. The polymerised tubulin ratio in H69/ VDS was higher than that of H69 and was decreased by the addition of verapamil in a dose-dependent manner ( Figure  8 ). This result was consistent with the reversal of vindesine resistance in H69/VDS by verapamil. Therefore we believe that the increase in total tubulin and/or the decrease in the polymerised tubulin ratio plays some role in the mechanism of H69/VDS resistance. It has previously been reported that a decrease in the total cellular tubulin pool occurs parallel with an increase in microtubule depolymerisation .
Taxol promotes the polymerisation of microtubules and stabilises tubulin polymers by preventing their depolymerisation. It seems that the manner of action of taxol on tubulin polymerisation is the reverse of that of vinca alkaloids. We therefore expected H69/VDS cells to show a hypersensitivity to taxol. However, H69/VDS cells showed cross-resistance to taxol. It has been reported that taxol does not competitively inhibit the binding of colchicine to tubulin (Schiff & Horwitz, 1981) . This suggests that the binding site of taxol may be different from that of colchicine. The cytotoxic action and cytotoxic profile of taxol may not therefore be completely adverse to those of vinca alkaloids. We thought it to be not unreasonable therefore that H69/VDS did not show hypersensitivity to taxol. However, it remains unclear why H69/ VDS did, in fact show cross-resistance to taxol. Further investigations are necessary to clarify this question.
Verapamil is known for its capacity to circumvent the typical multidrug resistance phenotype by reducing the increased drug efflux in the resistant cells (Yusa & Tsuruo, 1989) . On the other hand, verapamil has also been reported to potentiate drug effects in the absence of P-glycoprotein (Nygren & Larsson, 1990) . The effect of verapamil on tubulin, presented here, might indicate a new mode of action in circumvention of vinca alkaloid resistance other than by interaction with P-glycoprotein.
